The complex mechanistic aspects of redox-active compounds, commonly regarded as SOD mimics

BioInorganic Reaction Mechanisms

Volumn 9, Issue 1-4, 2013, Pages 35-58

  Batinic Haberle, Ines ^a   Tovmasyan, Artak ^a   Spasojevic, Ivan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Mn corroles; Mn polyamines; Mn porphyrins; Mn salens; SOD mimics

Indexed keywords

EID: 84925016288     PISSN: None     EISSN: 21912491     Source Type: Journal    
DOI: 10.1515/irm-2013-0004     Document Type: Review

References (219)

1. Abraham, S. K.; Sarma, L.; Kesavan, P. C. Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat. Res. 1993, 303, 109-112.
2. Aitken, J. B.; Shearer, E. L.; Giles, N. M.; Lai, B.; Vogt, S.; Reboucas, J. S.; Batinic-Haberle, I.; Lay, P. A.; Giles, G. I. Intracellular targeting and pharmacological activity of the superoxide dismutase mimics MnTE-2-PyP5+ and MnTnHex-2-PyP5+ regulated by their porphyrin ring substituents. Inorg. Chem. 2013, 52, 4121-4123.
3. Ali, D. K.; Oriowo, M.; Tovmasyan, A.; Batinic-Haberle, I.; Benov, L. Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications. Redox. Biol. 2013, 1, 457-466.
4. Amato, R. J.; Jac, J.; Hernandez-McClain, J. Motexafin gadolinium for the treatment of metastatic renal cell carcinoma, phase II study results. Clin. Genitourin. Cancer 2008, 6, 73-78.
5. Ansenberger-Fricano, K.; Ganini, D.; Mao, M.; Chatterjee, S.; Dallas, S.; Mason, R. P.; Stadler, K.; Santos, J. H.; Bonini, M. G. The peroxidase activity of mitochondrial superoxide dismutase. Free Radic. Biol. Med. 2013, 54, 116-124.
6. Archambeau, J. O.; Tovmasyan, A.; Pearlsten, R. D.; Crapo, J. D.; Batinic-Haberle, I. Superoxide dismutase mimic, MnTE-2-PyP5+ ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum. Redox Biol. 2013, 1, 599-607.
7. Archibald, F. S; Fridovich, I. The scavenging of superoxide radical by manganous complexes, in vitro. Arch. Biochem. Biophys. 1982, 214, 452-463.
8. Aston, K.; Rath, N.; Naik, A.; Slomczynska, U.; Schall, O. F.; Riley, D. P. Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg. Chem. 2001, 40, 1779-1789.
9. Bagga, P.; Patel, A. B. Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism. Neurochem. Int. 2012, 60, 177-185.
10. Bakthavatchalu, V.; Dey, S.; Xu, Y.; Noel, T.; Jungsuwadee P.; Holley, A. K.; Dhar, S. K.; Batinic-Haberle, I.; St. Clair, D. K. Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polgamma against UV-induced inactivation. Oncogene 2012, 31, 2129-2139.
11. Barnese, K.; Gralla, E. B.; Cabelli, D. E.; Valentine, J. S. Manganous phosphate acts as a superoxide dismutase. J. Am. Chem. Soc. 2008, 130, 4604-4606.
12. Batinic-Haberle, I.; Liochev, S. I.; Spasojevic, I.; Fridovich, I. A potent superoxide dismutase mimic: manganese beta-octabromo-meso-tetrakis(-N-methylpyridinium-4-yl) porphyrin. Arch. Biochem. Biophys. 1997, 343, 225-233.
13. Batinic-Haberle, I.; Benov, L.; Spasojevic, I.; Fridovich, I. The ortho effect makes manganese(III) meso-tetrakis(Nmethylpyridinium- 2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J. Biol. Chem. 1998, 273, 24521-24528.
14. Batinić-Haberle, I.; Spasojević, I.; Hambright, P.; Benov, L.; Crumbliss, A. L.; Fridovich, I. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in Vivo and in vitro superoxide dismutating activities of Manganese(III) and Iron(III) water-soluble porphyrins. Inorg. Chem. 1999, 38, 4011-4022.
15. Batinić-Haberle, I.; Spasojević, I.; Stevens, R. D.; Hambright, P.; Fridovich, I. Manganese(III) meso-tetrakis(ortho-N-alkylpyridyl) porphyrins. Synthesis, characterization, and catalysis of O2 - dismutation. J. Chem. Soc., Dalton Trans. 2002, 2689-96.
16. Batinic-Haberle, I.; Spasojevic, I.; Stevens, R. D.; Hambright, P.; Neta, P.; Okado-Matsumoto, A.; Fridovich, I. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyland di-ortho-methoxyethylimidazolylporphyrins. Dalton Trans. 2004, 11, 1696-1702.
17. Batinic-Haberle, I.; Spasojevic, I.; Stevens, R. D; Bondurant, B; Okado-Matsumoto, A; Fridovich, I; Vujaskovic, Z; Dewhirst, M. W. New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme. Dalton Trans. 2006, 4, 617-624.
18. Batinic-Haberle, I.; Cuzzocrea, S.; Reboucas, J. S.; Ferrer-Sueta, G.; Mazzon, E.; Di Paola, R.; Radi, R.; Spasojevic, I.; Benov, L.; Salvemini, D. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Free Radic. Biol. Med. 2009, 46, 192-201.
19. Batinic-Haberle, I.; Reboucas, J. S.; Spasojevic, I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid. Redox Signal. 2010, 13, 877-918.
20. Batinic-Haberle, I.; Rajic, Z.; Benov, L. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon. Anticancer Agents Med. Chem. 2011a, 11, 329-340.
21. Batinic-Haberle, I; Rajic, Z; Tovmasyan, A; Reboucas, J.S.; Ye, X.; Leong, K. W.; Dewhirst, M. W.; Vujaskovic, Z.; Benov, L.; Spasojevic, I. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic. Biol. Med. 2011b, 51, 1035-1053.
22. Batinic-Haberle, I.; Reboucas, J. S.; Benov, L.; Spasojevic, I. Chemistry, Biology and Medical Effects of Water Soluble Metalloporphyrins. In Handbook of Porphyrin Science. Kadish, K. M., Smith, K. M., Guillard, R., Eds. Singapore: World Scientific, 2011c, pp. 291-393.
23. Batinic-Haberle, I; Reboucas, J.S.; Spasojevic, I. Response to Rosenthal et al. Antioxid. Redox. Signal. 2011d, 14, 1174-1176.
24. Batinic-Haberle, I.; Spasojevic, I.; Tse H. M.; Tovmasyan, A.; Rajic, Z.; St. Clair, D. K.; Vujaskovic, Z.; Dewhirst, M. W.; Piganelli, J. D. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino Acids 2012, 42, 95-113.
25. Batinic-Haberle, I.; Tovmasyan, A.; Roberts, E.; Vujaskovic, Z.; Leong, K. W.; Spasojevic, I. SOD therapeutics: latest insights into their structure-activity relationships and impact upon the cellular redox-based pathways. Antioxid Redox Signal 2013, DOI: 10.1089/ars.2012.5147.
26. Baudry, M.; Etienne, S.; Bruce, A.; Palucki, M.; Jacobsen, E.; Malfroy, B. Salen-manganese complexes are superoxide dismutase-mimics. Biochem. Biophys. Res. Commun. 1993, 192, 964-968.
27. Belkacemi, A.; Doggui, S.; Dao, L.; Ramassamy, C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev. Mol. Med. 2011, 13, e34.
28. Benatar, M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 2007, 26, 1-13.
29. Benov, L.; Batinic-Haberle, I. A manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocindiabetic rats. Free Radic. Res. 2005, 39, 81-88.
30. Benov, L; Fridovich, I. Growth in iron-enriched medium partially compensates Escherichia coli for the lack of manganese and iron superoxide dismutase. J. Biol. Chem., 1998, 273, 10313-10316.
31. Bottino, R.; Balamurugan, A. N.; Tse, H.; Thirunavukkarasu, C.; Ge, X.; Profozich, J.; Milton, M.; Ziegenfuss, A.; Trucco, M.; Piganelli, J. D. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004, 53, 2559-2568.
32. Brennan M. L.; Wu W.; Fu X.; Shen Z.; Song W.; Frost H.; Vadseth C.; Narine L.; Lenkiewicz E.; Borchers M. T.; et al. A tale of two controversies, defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 2002, 277, 17415-17427.
33. Buettner, G. R. Superoxide dismutase in redox biology, the roles of superoxide and hydrogen peroxide. Anticancer Agents Med. Chem. 2011, 11, 341-346.
34. Buettner, G. R.; Ng, C. F.; Wang, M.; Rodgers, V. G.; Schafer, F. Q. A new paradigm, manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med. 2006, 41, 1338-13350.
35. Carballal, S.; Valez, V.; Batinic-Haberle, I.; Ferrer-Sueta, G.; Radi, R. Reactivity and Cytoprotective Capacity of the Synthetic Catalytic Antioxidants Mnporphyrins towards Peroxynitrite and Hypochlorite. Free Radic. Biol. Med. 2013, 65, S125-S122.
36. Carnieri, N.; Harriman, A.; Porter, G. Photochemistry of manganese porphyrins, part 6, oxidation-reduction equilibria of manganese(III) porphyrins in aqueous solution. J. Chem. Soc. Dalton Trans. 1982, 931-938.
37. Chen, Q.; Espey, M. G.; Krishna, M. C.; Mitchell, J. B.; Corpe, C. P.; Buettner, G. R.; Shacter, E.; Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells, action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA 2005, 102, 13604-13609.
38. Chen, Q.; Espey, M. G.; Sun, A. Y.; Lee, J. H.; Krishna, M. C.; Shacter, E.; Choyke, P. L.; Pooput, C; Kirk, K. L.; Buettner, G. R.; et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. USA 2007, 104, 8749-8754.
39. Chen, Q.; Espey, M. G.; Sun, A. Y.; Pooput, C.; Kirk, K. L.; Krishna, M. C.; Khosh, D. B.; Drisko, J.; Levine, M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA 2008, 105, 11105-11109.
40. Cheng, G.; Lopez, M.; Zielonka, J.; Hauser, A. D.; Joseph, J.; McAllister, D.; Rowe, J. J.; Sugg, S. L.; Williams, C. L.; Kalyanaraman, B. Mitochondria-targeted nitroxides exacerbate Fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells. Cancer Biol. Ther. 2011, 12, 707-717.
41. Chouchani, E. T.; Hurd, T. R.; Nadtochiy, S. M.; Brookes, P. S.; Fearnley, I. M.; Lilley, K. S.; Smith, R. A.; Murphy, M. P. Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE), implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem. J. 2010, 430, 49-59.
42. Cocheme, H. M.; Quin, C.; McQuaker, S. J.; Cabreiro, F.; Logan, A.; Prime, T. A.; Abakumova, I.; Patel, J. V.; Fearnley, I. M.; James, A. M.; et al. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab. 2011, 3, 340-350.
43. Cohen, J.; Dorai, T.; Ding, C.; Batinic-Haberle, I.; Grasso, M. The administration of renoprotective agents extends warm ischemia in a rat model. J. Endourol. 2013, 27, 343-348.
44. Colon, J.; Herrera, L.; Smith, J.; Patil, S.; Komanski, C.; Kupelian, P.; Seal, S.; Jenkins, D. W.; Baker, C. H. Protection from radiationinduced pneumonitis using cerium oxide nanoparticles. Nanomedicine 2009, 5, 225-231.
45. Colon, J.; Hsieh, N.; Ferguson, A.; Kupelian, P.; Seal, S.; Jenkins, D. W.; Baker, C. H. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 2010, 6, 698-705.
46. Csont, T.; Viappiani, S.; Sawicka, J.; Slee, S.; Altarejos, J. Y.; Batinic-Haberle, I.; Schulz, R. The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. J. Mol. Cell. Cardiol. 2005, 39, 833-840.
47. Cummins, T. D.; Higdon, A. N.; Kramer, P. A.; Chacko, B. K.; Riggs, D. W.; Salabei, J. K.; Dell'italia, L. J.; Zhang, J.; Darley-Usmar, V. M.; Hill, B. G. Utilization of fluorescent probes for the quantification and identification of subcellular proteomes and biological processes regulated by lipid peroxidation products. Free Radic. Biol. Med. 2013, 59, 56-68.
48. Cuzzocrea, S.; Mazzon, E.; Dugo, L.; Caputi, A. P.; Riley, D. P.; Salvemini, D. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur. J. Pharmacol. 2001, 432, 79-89.
49. Cuzzocrea, S.; Mazzon, E.; di Paola, R.; Genovese, T.; Muia, C.; Caputi, A. P.; Salvemini, D. Synergistic interaction between methotrexate and a superoxide dismutase mimetic - Pharmacologic and potential clinical significance. Arthritis Rheum. 2005, 52, 3755-3760.
50. Das, L; Vinayak, M. Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-kappaB signalling in lymphoma-bearing mice. Biosci. Rep. 2012, 32, 161-170.
51. Day, B. J. Antioxidant therapeutics, Pandora's box. Free Radic. Biol. Med. 2013.
52. Day, B. J.; Fridovich, I.; Crapo, J. D. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch. Biochem. Biophys. 1997, 347, 256-262.
53. DeFreitas-Silva, G.; Reboucas, J. S.; Spasojevic, I.; Benov, L.; Idemori, Y. M.; Batinic-Haberle, I. SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl) porphyrin equals that of the enzyme itself. Arch. Biochem. Biophys. 2008, 477, 105-112.
54. Delmastro-Greenwood, M. M.; Tse, H. M.; Piganelli, J. D. Effects of metalloporphyrins on reducing inflammation and autoimmunity. Antioxid Redox Signal 2013a, DOI: 10.1089/ars.2013.5257.
55. Delmastro-Greenwood, M. M.; Votyakova, T.; Goetzman, E.; Marre, M. L.; Previte, D. M.; Tovmasyan, A.; Batinic-Haberle, I.; Trucco, M.; Piganelli, J. D. Mn porphyrin regulation of aerobic glycolysis, implications on the activation of diabetogenic immune cells. Antioxid Redox. Signal 2013b, 19, 1902-1915.
56. Demicheli, V.; Quijano, C.; Alvarez, B.; Radi, R. Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide. Free Radic. Biol. Med. 2007, 42, 1359-1368.
57. Desideri, A.; Falconi, M.; Parisi, V.; Morante, S.; Rotilio, G. Is the activity-linked electrostatic gradient of bovine Cu, Zn superoxide dismutases conserved in homologous enzymes irrespective of the number and distribution of charges? Free Radic. Biol. Med. 1988, 5, 313-317.
58. Dessolin, J.; Schuler, M.; Quinart, A.; De Giorgi, F.; Ghosez, L.; Ichas, F. Selective targeting of synthetic antioxidants to mitochondria, towards a mitochondrial medicine for neurodegenerative diseases? Eur. J. Pharmacol. 2002, 447, 155-161.
59. Doctrow, S. R.; Huffman, K.; Marcus, C. B.; Tocco, G.; Malfroy, E.; Adinolfi, C. A.; Kruk, H.; Baker, K.; Lazarowych, N.; Mascarenhas, J.; et al. Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents, structure-activity relationship studies. J. Med. Chem. 2002, 45, 4549-4558.
60. Doctrow, S. R.; Baudry, M.; Huffman, K.; Malfroy, B.; Melov S. Salen Manganese Complexes, Multifunctional Catalytic Antioxidants Protective in Models for Neurodegenerative Diseases of Aging in Medicinal Inorganic Chemistry. In American Chemical Society Symposium Series 903, ACS. Sessler, J., Doctrow S. R., McMurry T., Lippard S, Eds. Oxford University Press, 2005, pp 319-347.
61. Dorai, T.; Fishman, A. I.; Ding, C.; Batinic-Haberle, I.; Goldfarb, D. S.; Grasso, M. Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail. J. Urol. 2011, 186, 2448-2454.
62. Dowding, J. M.; Dosani, T.; Kumar, A.; Seal, S.; Self, W. T. Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem. Commun. (Camb) 2012, 48, 4896-4898.
63. Eckshtain, M.; Zilbermann, I.; Mahammed, A.; Saltsman, I.; Okun, Z.; Maimon, E.; Cohen, H.; Meyerstein, D.; Gross, Z. Superoxide dismutase activity of corrole metal complexes. Dalton Trans. 2009, 7879-7882.
64. Evans, M. K.; Tovmasyan, A.; Batinic-Haberle, I.; Devi, G. R. Mn Porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death. Free Radic. Biol. Med. 2013, DOI: 10.1016/j.freeradbiomed.2013.11.031.
65. Fang, J.; Seki, T.; Maeda, H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv. Drug. Deliv. Rev. 2009, 61, 290-302.
66. Faraggi, M.; Peretz, P.; Weinraub, D. Chemical properties of water-soluble porphyrins. The reaction of a 'picket-fence-like' iron (III) complex with the superoxide oxygen couple. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1986, 49, 951-968.
67. Faulkner, K. M.; Liochev, S. I.; Fridovich, I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 1994a, 269, 23471-243476.
68. Faulkner, K. M.; Stevens, R. D.; Fridovich, I. Characterization of Mn(III) complexes of linear and cyclic desferrioxamines as mimics of superoxide dismutase activity. Arch. Biochem. Biophys. 1994b, 310, 341-346.
69. Ferrer-Sueta, G.; Batinic-Haberle, I.; Spasojevic, I.; Fridovich, I.; Radi, R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem. Res. Toxicol. 1999, 12, 442-449.
70. Ferrer-Sueta, G.; Quijano, C.; Alvarez, B.; Radi, R. Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite. Methods Enzymol 2002, 349, 23-37.
71. Ferrer-Sueta, G.; Vitturi, D.; Batinic-Haberle, I.; Fridovich, I.; Goldstein, S.; Czapski, G.; Radi, R. Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion. J. Biol. Chem. 2003, 278, 27432-27438.
72. Filipovic, M. R.; Stanic, D.; Raicevic, S.; Spasic, M.; Niketic, V. Consequences of MnSOD interactions with nitric oxide: Nitric oxide dismutation and the generation of peroxynitrite and hydrogen peroxide. Free Radic. Res. 2007, 41, 62-72.
73. Filipovic, M. R.; Duerr, K.; Mojovic, M.; Simeunovic, V.; Zimmermann, R.; Niketic, V.; Ivanovic-Burmazovic, I. NO Dismutase Activity of Seven-Coordinate Manganese(II) Pentaazamacrocyclic Complexes. Angewandte Chemie- International Edition 2008, 47, 8735-8739.
74. Filipovic, M. R.; Koh, A. C.; Arbault, S.; Niketic, V.; Debus, A.; Schleicher, U.; Bogdan, C.; Guille, M.; Lemaitre, F.; Amatore, C.; et al. Striking inflammation from both sides, manganese(II) pentaazamacrocyclic SOD mimics act also as nitric oxide dismutases, a single-cell study. Angewandte Chemie- International Edition 2010, 49, 4228-4232.
75. Forman, H. J.; Davies, K. J.; Ursini, F. How do nutritional antioxidants really work, Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 2013, DOI: 10.1016/j.freeradbiomed.2013.05.045.
76. Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64, 97-112.
77. Friedel, F. C.; Lieb, D.; Ivanovic-Burmazovic, I. Comparative studies on manganese-based SOD mimetics, including the phosphate effect, by using global spectral analysis. J. Inorg. Biochem. 2012, 109, 26-32.
78. Gad, S. C; Sullivan. D. W. Jr.; Crapo, J. D.; Spainhour, C. B. A Nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin. Int. J. Toxicol. 2013, 32, 274-287.
79. Gao, M. C.; Jia, X. D.; Wu, Q. F.; Cheng, Y.; Chen, F. R.; Zhang, J. Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation. Acta Pharmacol. Sin. 2011, 32, 528-536.
80. Gaut, J. P.; Byun, J.; Tran, H. D.; Lauber, W. M.; Carroll, J. A.; Hotchkiss, R. S.; Belaaouaj, A.; Heinecke, J. W. Myeloperoxidase produces nitrating oxidants in vivo. J. Clin. Invest. 2002, 109, 1311-1319.
81. Getzoff, E. D.; Tainer, J. A.; Weiner, P. K.; Kollman, P. A.; Richardson, J. S.; Richardson, D.C. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature 1983, 306, 287-290.
82. Giles, S. S.; Batinic-Haberle, I.; Perfect, J. R.; Cox, G. M. Cryptococcus neoformans mitochondrial superoxide dismutase, an essential link between antioxidant function and high-temperature growth. Eukaryot. Cell 2005, 4, 46-54.
83. Goldstein, S.; Czapski, G.; Heller, A. Osmium tetroxide, used in the treatment of arthritic joints, is a fast mimic of superoxide dismutase. Free Radic. Biol. Med. 2005, 38, 839-845.
84. Goldstein, S.; Samuni, A.; Hideg, K.; Merenyi, G. Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J. Phys. Chem. A 2006, 110, 3679-3685.
85. Gu, M.; Imlay, J. A. Superoxide poisons mononuclear iron enzymes by causing mismetallation. Mol. Microbiol. 2013, 89, 123-134.
86. Haber, A.; Mahammed, A.; Fuhrman, B.; Volkova, N.; Coleman, R.; Hayek, T.; Aviram, M.; Gross Z. Amphiphilic/bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in mice. Angew. Chem. Int. Ed. 2008, 47, 7896-7900.
87. Hachmeister, J. E.; Valluru, L.; Bao, F.; Liu, D. Mn (III) tetrakis (4-benzoic acid) porphyrin administered into the intrathecal space reduces oxidative damage and neuron death after spinal cord injury, a comparison with methylprednisolone. J. Neurotrauma 2006, 23, 1766-1778.
88. Halliwell, B. Free radicals and antioxidants, updating a personal view. Nutr. Rev. 2012, 70, 257-265.
89. Halliwell, B.; Gutteridge, J. M. Free Radicals in Biology and Medicine; Oxford University Press: New York, 2007.
90. Heckert, E. G.; Karakoti, A. S.; Seal, S.; Self, W. T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008, 29, 2705-2709.
91. Hempel, N.; Carrico, P. M.; Melendez, J. A. Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med. Chem. 2011, 11, 191-201.
92. Hoffer, L. J.; Levine, M.; Assouline, S.; Melnychuk, D.; Padayatty, S. J.; Rosadiuk, K.; Rousseau, C.; Robitaille, L.; Miller, W. H. Jr. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann. Oncol. 2008, 19, 1969-1974.
93. Holley, A. K.; Xu, Y.; Noel, T.; Bakthavatchalu, V.; Batinic-Haberle, I.; Clair, D. K. Manganese superoxide dismutase-mediated inside-out signaling in HaCaT human keratinocytes and SKH-1 mouse skin. Antioxid Redox Signal In revision, 2013.
94. Hudnell, H. K. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology 1999, 20, 379-397.
95. Hyman, L. M.; Franz, K. J. Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols. Coord. Chem. Rev. 2012, 256, 2333-2356.
96. Ilan, Y.; Rabani, J.; Fridovich, I.; Pasternack, J. M. Superoxide dismuting activity of an iron porphyrin. Inorg. Nucl. Chem. Lett. 1981, 17, 93-96.
97. Imlay, J. A. How oxygen damages microbes: Oxygen tolerance and obligate anaerobiosis. Adv. Microb. Physiol. 2002, 46, 111-153.
98. Imlay, J. A. Pathways of Oxidative Damage. Annu. Rev. Microbiol. 2003, 57, 395-418.
99. Imlay, J. A. Iron-sulphur clusters and the problem with oxygen. Mol. Microbiol. 2006, 59, 1073-1082.
100. Imlay, J. A. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 2008, 77, 755-776.
101. James, A. M.; Cocheme, H. M.; Smith, R. A.; Murphy, M. P. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 2005, 280, 21295-21312.
102. Jaramillo, M. C.; Frye, J. B.; Crapo, J. D.; Briehl, M. M.; Tome, M. E. Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells. Cancer Res. 2009, 69, 5450-5457.
103. Jaramillo, M. C.; Briehl, M. M.; Tome, M. E. Manganese porphyrin glutathionylates the p65 subunit of NF-κB to potentiate glucocorticoid-induced apoptosis in lymphoma. Free Radic. Biol. Med. 2010, 49, S63.
104. Jaramillo, M. C.; Briehl, M. M.; Crapo, J. D.; Batinic-Haberle, I.; Tome, M. E. Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells. Free Radic. Biol. Med. 2012, 52, 1272-1284.
105. Jaramillo, M.; Briehl, M. M.; Batinic-Haberle, I.; Tome, M. Inhibition of the electron transport chain via the prooxidative activity of manganese porphyrin-based SOD mimetics modulates bioenergetics and enhances the response to chemotherapy. Antioxid. Redox Signal: In Revision, 2013a.
106. Jaramillo, M. C.; Briehl, M. M.; Batinic Haberle, I.; Tome, M. E. Manganese porphyrin glutathionylates mitochondrial electron transport chain enzymes and sensitizes lymphoma cells to anti-lymphoma therapeutics. Free Radic. Biol. Med. 2013b, 65, S25.
107. Jiao, X. Y.; Gao, E.; Yuan, Y.; Wang, Y.; Lau, W. B.; Koch, W.; Ma, X. L.; Tao, L. INO-4885 [5,10,15,20-tetra]N(-benzyl-4'-carboxylate)-2- pyridinium[-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice. J. Pharmacol. Exp. Ther. 2009, 328, 777-784.
108. Jin, N.; Lahaye, D. E.; Groves, J. T. A "push-pull" mechanism for heterolytic o-o bond cleavage in hydroperoxo manganese porphyrins. Inorg. Chem. 2010, 49, 11516-11524.
109. Jumbo-Lucioni, P. P.; Ryan, E. L.; Hopson, M. L.; Bishop, H. M.; Weitner, T.; Tovmasyan, A.; Spasojevic, I.; Batinic-Haberle, I.; Liang, Y.; Jones, D. P.; et al. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a drosophila melanogaster model of classic galactosemia. Antioxid. Redox Signal 2013, DOI: 10.1089/ ars.2012.5122.
110. Jung, C.; Rong, Y.; Doctrow, S.; Baudry, M.; Malfroy, B.; Xu, Z. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci. Lett. 2001, 304, 157-160.
111. Kachadourian, R.; Batinić-Haberle, I.; Fridovich, I. Syntheses and superoxide dismuting activities of partially (1-4) β-chlorinated derivatives of manganese(III) meso-tetrakis(Nethylpyridinium- 2-yl)porphyrin. Inorg. Chem. 1999, 38, 391-396.
112. Kalyanaraman, B. Oxidative chemistry of fluorescent dyes: implications in the detection of reactive oxygen and nitrogen species. Biochem. Soc. Trans. 2011, 39, 1221-1225.
113. Kelso, G. F.; Maroz, A.; Cocheme, H. M.; Logan, A.; Prime, T. A.; Peskin, A. V.; Winterbourn, C. C.; James, A. M.; Ross, M. F.; Brooker, S.; et al. A mitochondria-targeted macrocyclic Mn(II) superoxide dismutase mimetic. Chem. Biol. 2012, 19, 1237-1246.
114. Kim, A.; Joseph, S.; Khan, A.; Epstein, C. J.; Sobel, R.; Huang, T. T. Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin. Free Radic. Biol. Med. 2010, 48, 1501-1512.
115. Koppenol, W. H. The Physiological Role of the Charge Distribution on Superoxide Dismutase. In Oxygen and Oxyradicals in Chemistry and Biology, Rodgers, M. A., Powers E. L., Eds. Academic Press: New York, 1981, pp 671-674.
116. Korsvik, C.; Patil, S.; Seal, S.; Self, W. T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (Camb) 2007, 10, 1056-1058.
117. Kumar, A.; Loo, S.; Shin, S. W.; Tuan, Z. T.; Chon, B. E.; Singh, R.; Putti, T.; Ong, C. W.; Salto-Tellez, M.; Goh, B. C.; et al. Targeting MnSOD in basal breast carcinoma using agonists of PPARγ: A new strategy for enhancing chemosensitivity. Antioxid. Redox Signal: In revision, 2013, DOI: 10.1089/ars.2013.5295.
118. Kwei, K. A.; Finch, J. S.; Thompson, E. J.; Bowden, G. T. Transcriptional repression of catalase in mouse skin tumor progression. Neoplasia 2004, 6, 440-448.
119. Lange, M.; Szabo, C.; Enkhbaatar, P.; Connelly, R.; Horvath, E.; Hamahata, A.; Cox, R. A.; Esechie, A.; Nakano, Y.; Traber, L. D.; et al. Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 300, L167-L175.
120. Lee, J. B.; Hunt, J. A.; Groves, J. T. Mechanisms of iron porphyrin reactions with peroxynitrite. J. Am. Chem. Soc. 1998, 120, 7493-7501.
121. Levine, M.; Espey, M. G.; Chen, Q. Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatment. Free Radic. Biol. Med. 2009, 47, 27-29.
122. Li, Q. X.; Luo, Q. H.; Li, Y. Z.; Shen, M. C. A study on the mimics of Cu-Zn superoxide dismutase with high activity and stability: two copper(II) complexes of 1,4,7-triazacyclononane with benzimidazole groups. Dalton Trans. 2004, 2329-2335.
123. Liberman, E. A.; Topaly, V. P.; Tsofina, L. M.; Jasaitis, A. A.; Skulachev, V. P. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 1969, 222, 1076-1078.
124. Lide, D. R. editor. Handbook of Chemistry and Physics; CRC Press, Inc.: 1993-1994.
125. Lieb, D.; Kenkel, I.; Miljkovic, J.; Weber, N.; Filipovic, M. R.; Grohn, F.; Ivanovic-Burmazovic, I. Amphiphilic pentaazamacrocyclic manganese superoxide dismutase mimetics. Inorg. Chem. accepted for publication, 2013.
126. Limtrakul, P.; Lipigorngoson, S.; Namwong, O.; Apisariyakul, A.; Dunn, F. W. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett. 1997, 116, 197-203.
127. Ling, X.; Liu, D. Temporal and spatial profiles of cell loss after spinal cord injury: Reduction by a metalloporphyrin. J. Neurosci. Res. 2007, 85, 2175-2185.
128. Liochev, S. I. Superoxide dismutase mimics, other mimics, antioxidants, prooxidants and related matters. Chem. Res. Toxicol. 2013, 26, 1312-1319.
129. Macarthur, H.; Westfall, T. C.; Riley, D. P.; Misko, T. P.; Salvemini, D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc. Natl. Acad. Sci. USA 2000, 97, 9753-9758.
130. MacMillan-Crow, L. A.; Crow, J. P. Does more MnSOD mean more hydrogen peroxide? Anticancer Agents Med. Chem. 2011, 11, 178-180.
131. Mahammed, A.; Gross Z. Highly efficient catalase activity of metallocorroles. Chem. Commun. (Camb) 2010, 46, 7040-7042.
132. Maroz, A.; Kelso, G. F.; Smith, R. A.; Ware, D. C.; Anderson, R. F. Pulse radiolysis investigation on the mechanism of the catalytic action of Mn(II)-pentaazamacrocycle compounds as superoxide dismutase mimetics. J. Phys. Chem. A 2008, 112, 4929-4935.
133. Masini, E.; Bani, D.; Vannacci, A.; Pierpaoli, S.; Mannaioni, P. F.; Comhair, S. A.; Xu, W.; Muscoli, C.; Erzurum, S. C.; Salvemini, D. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic. Biol. Med. 2005, 39, 520-531.
134. Maybauer, D. M.; Maybauer, M. O.; Szabo, C.; Cox, R. A.; Westphal, M.; Kiss, L.; Horvath, E. M.; Traber, L. D.; Hawkins, H. K.; Salzman, A. L.; et al. The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shock. Shock 2011, 35, 148-155.
135. McDonald, M. C.; d'Emmanuele di Villa Bianca, R.; Wayman, N. S.; Pinto, A.; Sharpe, M. A.; Cuzzocrea, S.; Chatterjee, P. K.; Thiemermann, C. A superoxide dismutase mimetic with catalase activity (EUK-8) reduces the organ injury in endotoxic shock. Eur. J. Pharmacol. 2003, 466, 181-189.
136. Messner, K. R.; Imlay, J. A. The identification of primary sites of superoxide and hydrogen peroxide formation in the aerobic respiratory chain and sulfite reductase complex of Escherichia coli. J. Biol. Chem. 1999, 274, 10119-10128.
137. Miljkovic, J.; Filipovic, M. R.; Otasevic, V.; Stancic, A.; Jankovic, A.; Vucetic, M.; Buzadzic, B.; Lieb, D.; Zimmermann, R.; Korac, A.; et al. Redox modulation of cell signaling in healthy and diabetic animals by pentaazamacrocyclic MnSOD mimics: cross-reactivity with NO as a new therapeutic approach. Antioxid. Redox Signal In revision, 2013.
138. Miriyala, S.; Spasojevic, I.; Tovmasyan, A.; Salvemini, D.; Vujaskovic, Z.; St. Clair, D.; Batinic-Haberle, I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim. Biophys. Acta 2012, 1822, 794-814.
139. Monti, D. A.; Mitchell, E.; Bazzan, A. J.; Littman, S.; Zabrecky, G.; Yeo, C. J.; Pillai, M. V.; Newberg, A. B.; Deshmukh, S.; Levine, M. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 2012, 7, e29794.
140. Munroe, W.; Kingsley, C.; Durazo, A.; Gralla, E. B.; Imlay, J. A.; Srinivasan, C.; Valentine, J. S. Only one of a wide assortment of manganese-containing SOD mimicking compounds rescues the slow aerobic growth phenotypes of both Escherichia coli and Saccharomyces cerevisiae strains lacking superoxide dismutase enzymes. J. Inorg. Biochem. 2007, 101, 1875-1882.
141. Murphy, M. P. Targeting lipophilic cations to mitochondria. Biochim. Biophys. Acta 2008, 1777, 1028-1031.
142. Murphy, M. P.; Smith, R. A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 629-656.
143. Murphy, C. K.; Fey, E. G.; Watkins, B. A.; Wong, V.; Rothstein, D.; Sonis, S. T. Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. Clin. Cancer Res. 2008, 14, 4292-4297.
144. Muscoli, C.; Cuzzocrea, S.; Ndengele, M. M.; Mollace, V.; Porreca, F.; Fabrizi, F.; Esposito, E.; Masini, E.; Matuschak, G. M.; Salvemini, D. Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J. Clin. Invest. 2007, 117, 3530-3539.
145. Nonn, L.; Berggren, M.; Powis, G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 2003, 1, 682-689.
146. Oberley, L. W.; Leuthauser, S. W.; Pasternack, R. F.; Oberley, T. D.; Schutt, L.; Sorenson, J. R. Anticancer activity of metal compounds with superoxide dismutase activity. Agents Actions 1984, 5, 535-538.
147. Okado-Matsumoto, A.; Fridovich, I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 2001, 276, 38388-38393.
148. Okado-Matsumoto, A.; Batinic-Haberle, I.; Fridovich, I. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity. Free Radic. Biol. Med. 2004, 37, 401-410.
149. Okun, Z; Gross, Z. Fine tuning the reactivity of corrole-based catalytic antioxidants. Inorg. Chem. 2012, 51, 8083-8090.
150. Okun, Z.; Kupershmidt, L.; Amit, T.; Mandel, S.; Bar-Am, O.; Youdim, M. B.; Gross, Z. Manganese corroles prevent intracellular nitration and subsequent death of insulinproducing cells. ACS Chem. Biol. 2009, 4, 910-914.
151. Orrell, R. W. AEOL-10150 (Aeolus). Curr. Opin. Investig. Drugs 2006, 7, 70-80.
152. Otasevic, V.; Korac, A.; Vucetic, M.; Macanovic, B.; Garalejic, E.; Ivanovic-Burmazovic, I.; Filipovic, M. R.; Buzadzic, B.; Stancic, A.; Jankovic, A.; et al. Is manganese (II) pentaazamacrocyclic superoxide dismutase mimic beneficial for human sperm mitochondria function and motility? Antioxid Redox Signal 2013, 18, 170-178.
153. Padayatty, S. J.; Levine, M. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity. J. Am. Coll. Nutr. 2000, 19, 423-425.
154. Padayatty, S. J.; Sun, H.; Wang, Y.; Riordan, H. D.; Hewitt, S. M.; Katz, A.; Wesley, R. A.; Levine, M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 2004, 140, 533-537.
155. Pasternack, R. F.; Halliwell, B. Superoxide dismutase activities of an iron porphyrin and other iron complexes. J. Am. Chem. Soc. 1979, 101, 1026-1031.
156. Pasternack, R. F.; Banth, A.; Pasternack, J. M.; Johnson, C. S. Catalysis of the disproportionation of superoxide by metalloporphyrins. III. J. Inorg. Biochem. 1981, 15, 261-267.
157. Pate, K.; Dunham, K.; Padgett, L.; Tse, H.; Floyd, C.; Crapo, J. MnTnBuOE-2-PyP5+ is neuroprotective following acute cervical spinal cord injury in rats. Free Radic. Biol. Med. 2012, 53, S114.
158. Peretz, P.; Solomon, D.; Weinraub, D.; Faraggi, M. Chemical properties of water-soluble porphyrins 3. The reaction of superoxide radicals with some metalloporphyrins. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1982, 42, 449-456.
159. Pieper, G. M.; Nilakantan, V.; Chen, M.; Zhou, J.; Khanna, A. K.; Henderson, J. D., Jr.; Johnson, C. P.; Roza, A. M.; Szabo, C. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J. Pharmacol. Exp. Ther. 2005, 314, 53-60.
160. Pirmohamed, T.; Dowding, J. M.; Singh, S.; Wasserman, B.; Heckert, E.; Karakoti, A. S.; King, J. E.; Seal, S.; Self, W. T. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. (Camb) 2010, 46, 2736-2738.
161. Quijano, C.; Hernandez-Saavedra, D.; Castro, L.; McCord, J. M.; Freeman, B. A.; Radi, R. Reaction of peroxynitrite with Mn-superoxide dismutase. Role of the metal center in decomposition kinetics and nitration. J. Biol. Chem. 2001, 276, 11631-11638.
162. Radovits, T.; Beller, C. J.; Groves, J. T.; Merkely, B.; Karck, M.; Szabo, C.; Szabo, G. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 2012, 41, 391-396..
163. Rajic, Z.; Tovmasyan, A.; Spasojevic, I.; Sheng, H.; Lu, M.; Li, A. M.; Gralla, E. B.; Warner, D. S.; Benov, L.; Batinic-Haberle, I. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity. Free Radic. Biol. Med. 2012, 52, 1828-1834.
164. Rawal, M.; Schroeder, S. R.; Wagner, B. A.; Cushing, C. M.; Welsh, J. L.; Button, A. M.; Du, J.; Sibenaller, Z. A.; Buettner, G. R.; Cullen, JJ. Manganoporphyrins Increase Ascorbate-Induced Cytotoxicity by Enhancing H2O2 Generation. Cancer Res 2013, 73, 5232-5241.
165. Reboucas, J. S.; DeFreitas-Silva, G.; Spasojevic, I.; Idemori, Y. M.; Benov, L.; Batinic-Haberle, I. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier. Free Radic. Biol. Med. 2008a, 45, 201-210.
166. Reboucas, J. S.; Spasojevic, I.; Batinic-Haberle, I. Pure manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is not a superoxide dismutase mimic in aqueous systems: a case of structure-activity relationship as a watchdog mechanism in experimental therapeutics and biology. J. Biol. Inorg. Chem. 2008b, 13, 289-302.
167. Reboucas, J. S.; Spasojevic, I.; Batinic-Haberle, I. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes. J. Pharm. Biomed. Anal. 2008c, 48, 1046-1049.
168. Riley, D. P. Rational Design of Synthetic Enzymes and Their Potential Utility as Human Pharmaceuticals: Development of Manganese(II)-based Superoxide Dismutase Mimics. In Advances in Supramolecular Chemistry, Gokel, G. W., Ed. JAI Press Inc.,: Stanford, 2000, pp 217-244.
169. Riley, D. P.; Lennon, P. J.; Neumann, W. L.; Weiss, R. H. Toward the rational design of superoxide dismutase mimics: mechanistic studies for the elucidation of substituent effects on the catalytic activity of macrocyclic manganese(II) complexes J. Am. Chem. Soc. 1997, 119, 6522-6528.
170. Riordan, H. D.; Riordan, N. H.; Jackson, J. A.; Casciari, J. J.; Hunninghake, R.; Gonzalez, M. J.; Mora, E. M.; Miranda- Massari, J. R.; Rosario, N.; Rivera, A. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci. J. 2004, 23, 115-118.
171. Roth, J. A. Homeostatic and toxic mechanisms regulating manganese uptake; retention; and elimination. Biol. Res. 2006, 39, 45-57.
172. Salvemini, D.; Wang, Z. Q.; Zweier, J. L.; Samouilov, A.; Macarthur, H.; Misko, T. P.; Currie, M. G.; Cuzzocrea, S.; Sikorski, J. A.; Riley, D. P. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999, 286, 304-306.
173. Sampson, N.; Koziel, R.; Zenzmaier, C.; Bubendorf, L.; Plas, E.; Jansen-Durr, P.; Berger, P. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 2011, 25, 503-515.
174. Sharpe, M. A.; Ollosson, R.; Stewart, V. C.; Clark, J. B. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/ catalase mimetics. Biochemical. J. 2002, 366, 97-107.
175. Shen, K. K.; Ji, L. L.; Chen, Y.; Yu, Q. M.; Wang, Z. T. Influence of glutathione levels and activity of glutathione-related enzymes in the brains of tumor-bearing mice. Biosci. Trends 2011, 5, 30-37.
176. Sheng, H.; Enghild, J. J.; Bowler, R.; Patel, M.; Batinic-Haberle, I.; Calvi, C. L.; Day, B. J.; Pearlstein, R. D.; Crapo, J. D.; Warner, D. S. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic. Biol. Med. 2002, 33, 947-961.
177. Sheng, H.; Spasojevic, I.; Tse, H. M.; Jung, J. Y.; Hong, J.; Zhang, Z.; Piganelli, J. D.; Batinic-Haberle, I.; Warner, D. S. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: Rodent models of ischemic stroke and subarachnoid hemorrhage. J. Pharmacol. Exp. Ther. 2011, 338, 906-916.
178. Sheng, H.; Chaparro, R. E.; Sasaki, T.; Izutsu, M.; Pearlstein, R. D.; Tovmasyan, A.; Warner, D. S. Metalloporphyrins as therapeutic catalytic oxidoreductants in central nervous system disorders. Antioxid Redox Signal 2013, DOI: 10.1089/ars.2013.5413.
179. Shimanovich, R.; Groves, J. T. Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 2001, 387, 307-317.
180. Singh, S.; Kumar, A.; Karakoti, A.; Seal, S.; Self, W. T. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol. Biosyst. 2010, 6, 1813-1820.
181. Smith, R. M.; Martell, A. E. Critical Stability Constants; Plenum Press: New York, 1989.
182. Soriano, F. G.; Lorigados, C. B.; Pacher, P.; Szabo, C. Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis. Shock 2011, 35, 560-566.
183. Sorokina, L. V.; Solyanik, G. I.; Pyatchanina, T. V. The evaluation of prooxidant and antioxidant state of two variants of lewis lung carcinoma: a comparative study. Exp. Oncol. 2010, 32, 249-253.
184. Spasojevic, I.; Batinic-Haberle, I. Superoxide Dismutase Mimics. In Principles of Free Radical Biomedicine. Pantopoulos, K., Schipper, H., Eds. Nova Science Publishers: Hauppauge, N.Y., 2010.
185. Spasojevic, I.; Batinic-Haberle, I.; Fridovich, I. Nitrosylation of manganese(II) tetrakis(N-ethylpyridinium-2-yl)porphyrin: a simple and sensitive spectrophotometric assay for nitric oxide. Nitric Oxide 2000, 4, 526-533.
186. Spasojevic, I.; Batinic-Haberle, I.; Stevens, R. D.; Hambright, P.; Thorpe, A. N.; Grodkowski, J.; Neta, P.; Fridovich, I. Manganese(III) biliverdin IX dimethyl ester: A powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple. Inorg. Chem. 2001, 40, 726-739.
187. Spasojevic, I.; Batinic-Haberle, I.; Reboucas, J. S.; Idemori, Y. M.; Fridovich, I. Electrostatic contribution in the catalysis of O2- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+. J. Biol. Chem. 2003, 278, 6831-6837.
188. Spasojevic, I.; Chen, Y.; Noel, T. J.; Yu, Y.; Cole, M. P.; Zhang, L.; Zhao, Y.; St. Clair, D. K.; Batinic-Haberle, I. Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria. Free Radic. Biol. Med. 2007, 42, 1193-1200.
189. Spasojevic, I.; Chen, Y.; Noel, T. J.; Fan, P.; Zhang, L.; Reboucas, J. S.; St. Clair, D. K.; Batinic-Haberle, I. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2- PyP(5+), in plasma and major organs of B6C3F1 mice. Free Radic. Biol. Med. 2008, 45, 943-949.
190. Spasojevic, I.; Li, A.; Tovmasyan, A.; Rajic, Z.; Salvemini, D.; St. Clair, D.; Valentine, J. S.; Vujaskovic, Z.; Gralla, E. B.; Batinic-Haberle, I. Accumulation of porphyrin-based SOD mimics in mitochondria is proportional to their lipophilicity: S. cerevisiae study of ortho Mn(III) N-alkylpyridylporphyrins. Free Radic. Biol. Med. 2010, 49, S199.
191. Spasojevic, I; Miryala, S; Tovmasyan, A; Salvemini, D; Vujaskovic, Z; Batinic-Haberle, I; St. Clair, D. Lipophilicity of Mn(III) N-alkylpyridylporphyrins dominates their accumulation within mitochondria and therefore in vivo efficacy. A mouse study. Free Radic. Biol. Med. 2011, 51, S98.
192. Suganuma, M.; Saha, A.; Fujiki, H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 2011, 102, 317-323.
193. Szabo, C.; Ischiropoulos, H.; Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug. Discov. 2007, 6, 662-680.
194. Szabo, G.; Loganathan, S.; Merkely, B.; Groves, J. T.; Karck, M.; Szabo, C.; Radovits, T. Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation. J. Thorac. Cardiovasc. Surg. 2012, 143, 1443-1449.
195. Tantra, R.; Cackett, A.; Peck, R.; Gohil, D.; Snowden, J. Measurement of redox potential in nanoecotoxicological investigations. J. Toxicol. 2012, 270651.
196. Tarnuzzer, R. W.; Colon, J.; Patil, S.; Seal, S. Vacancy engineered ceria nanostructures for protection from radiation induced cellular damage. Nano. Lett. 2005, 5, 2573-2577.
197. Thompson, J. S.; Chu, Y.; Glass, J.; Tapp, A. A.; Brown, S. A. The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Radic. Res. 2010, 44, 529-540.
198. Tian, J.; Peehl, D. M.; Knox, S. J. Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry. Cancer Biother. Radiopharm. 2010, 25, 439-448.
199. Tovmasyan, A. G.; Rajic, Z.; Spasojevic, I.; Reboucas, J. S.; Chen, X.; Salvemini, D.; Sheng, H.; Warner, D. S.; Benov, L.; Batinic- Haberle, I. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Dalton Trans. 2011, 40, 4111-4121.
200. Tovmasyan, A.; Weitner, T.; Roberts, E.; Jaramillo, M.; Spasojevic, I.; Leong, K.; Tome, M.; Benov, L.; Batinic-Haberle, I. Understanding differences in mechanisms of action of Fe vs Mn porphyrins: comparison of their reactivities towards cellular reductants and reactive species. Free Radic. Biol. Med. 2012, 53, S120.
201. Tovmasyan, A.; Reboucas, J. S.; Benov, L.T. Simple biological systems for assessing the activity of SOD mimics. Antioxid Redox Signal 2013a, DOI: 10.1089/ars.2013.5576.
202. Tovmasyan, A.; Sheng, H.; Weitner, T.; Arulpragasam, A.; Lu, M.; Warner, D. S.; Vujaskovic, Z.; Spasojevic, I.; Batinic-Haberle, I. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. Med. Princ. Pract. 2013b, 22, 103-130.
203. Tovmasyan, A.; Weitner, T.; Jaramillo, M.; Wedmann, R.; Roberts, E.; Leong, K. W.; Filipovic, M.; Ivanovic-Burmazovic, I.; Benov, L.; Tome, M.; et al. We have come a long way with Mn porphyrins: from superoxide dismutation to H2O2-driven pathways. Free Rad. Biol. Med., 2013c, 65, S133.
204. Tovmasyan, A.; Weitner, T.; Sheng, H.; Lu, M.; Rajic, Z.; Warner, D. S.; Spasojevic, I.; Reboucas, J. S.; Benov, L.; Batinic- Haberle, I. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology. Inorg. Chem. 2013d, 52, 5677-5691.
205. Tse, H. M.; Milton, M. J.; Piganelli, J. D. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic. Biol. Med. 2004, 36, 233-247.
206. van Empel, V. P.; Bertrand, A. T.; van Oort, R. J.; van der Nagel, R.; Engelen, M.; van Rijen, H. V.; Doevendans, P. A.; Crijns, H. J.; Ackerman, S. L.; Sluiter, W.; et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J. Am. Coll. Cardiol. 2006, 48, 824-832.
207. Viani, G. A.; Manta, G. B.; Fonseca, E. C.; De Fendi, L. I.; Afonso, S. L.; Stefano, E. J. Whole brain radiotherapy with radiosensitizer for brain metastases. J. Exp. Clin. Cancer Res. 2009, 28, 1.
208. Wang, M.; Kirk, J. S.; Venkataraman, S.; Domann, F. E.; Zhang, H. J.; Schafer, F. Q.; Flanagan, S. W.; Weydert, C. J.; Spitz, D. R.; Buettner, G. R.; et al. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene 2005, 24, 8154-8166.
209. Weinraub, D.; Peretz, P.; Faraggi, M. Chemical properties of water-soluble porphyrins. 1. Equilibriums between some ligands and iron(III) tetrakis(4-N-methylpyridyl)porphyrin. J. Phys. Chem. A 1982, 86, 1839-1842.
210. Weinraub, D.; Levy, P.; Faraggi, M. Chemical properties of water-soluble porphyrins. 5. Reactions of some manganese (III) porphyrins with the superoxide and other reducing radicals. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1986, 50, 649-658.
211. Weitner, T.; Kos, I.; Sheng, H.; Tovmasyan, A.; Reboucas, J. S.; Fan, P.; Warner, D. S.; Vujaskovic, Z.; Batinic-Haberle, I.; Spasojevic, I. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP(5+) and MnTnHex-2-PyP(5+). Free Radic. Biol. Med. 2013, 58, 73-80.
212. Welsh, J. J.; Du, J.; Sibenaller, Z. A.; Kalen, A. L.; Wagner, B. A.; Allen, B. G.; Spitz, D. R.; Goswami, P. C.; Buettner, G. R.; Cullen, J. J. Ascorbate is a radiosensitizer in pancreatic caner. Free Rad. Biol. Med. 2012, 53, S52.
213. Welsh, J. L.; Wagner, B. A.; van't Erve, T. J.; Zehr, P. S.; Berg, D. J.; Halfdanarson, T. R.; Yee, N. S.; Bodeker, K. L.; Du, J.; Roberts, L. J., 2nd; et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother. Pharmacol. 2013, 71, 765-775.
214. Winterbourn, C. C. The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim. Biophys. Acta 2013, DOI: 10.1016/j.bbagen.2013.05.004.
215. Winterbourn, C. C; Peskin, A. V.; Parsons-Mair, H. N. Thiol oxidase activity of copper, zinc superoxide dismutase. J. Biol. Chem. 2002, 277, 1906-1911.
216. Xu, Y.; Liu, B.; Zweier, J. L.; He, G. Formation of hydrogen peroxide and reduction of peroxynitrite via dismutation of superoxide at reperfusion enhances myocardial blood flow and oxygen consumption in postischemic mouse heart. J. Pharmacol. Exp. Ther. 2008, 327, 402-410.
217. Ye, X.; Fels, D.; Tovmasyan, A.; Aird, K. M.; Dedeugd, C.; Allensworth, J. L.; Kos, I.; Park, W.; Spasojevic, I; Devi, G. R.; et al. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate. Free Radic. Res. 2011, 45, 1289-1306.
218. Zhao, Y.; Xue, Y.; Oberley, T. D.; Kiningham, K. K.; Lin, S. M.; Yen, H. C.; Majima, H.; Hines, J; St. Clair, D. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001, 61, 6082-6088.
219. Zhao, Y.; Chaiswing, L.; Oberley, T. D.; Batinic-Haberle, I.; St. Clair, W.; Epstein, C. J.; St. Clair, D. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 2005, 65, 1401-1405.